Ultralife Corp. (NASDAQ: ULBI) reported Q2 EPS of $0.07, $0.06 worse than the analyst estimate of $0.13. Revenue for the quarter came in at $48.6 million versus the consensus estimate of $51 million.

For earnings history and earnings-related data on Ultralife Corp. (ULBI) click here.